Belite Bio Inc ADR (BLTE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | N/A | -31,632 | N/A | N/A |
| Depreciation Amortization | N/A | N/A | 399 | N/A | N/A |
| Other Working Capital | N/A | N/A | -2,183 | N/A | N/A |
| Other Operating Activity | 0 | 0 | 3,579 | 0 | 0 |
| Operating Cash Flow | $N/A | $N/A | $-29,837 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -63 | N/A | N/A |
| Investing Cash Flow | $N/A | $N/A | $-63 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 77,189 | N/A | N/A |
| Other Financing Activity | 0 | 0 | -1,230 | 0 | 0 |
| Financing Cash Flow | $N/A | $N/A | $75,959 | $N/A | $N/A |
| Exchange Rate Effect | N/A | N/A | 9 | N/A | N/A |
| Beginning Cash Position | N/A | N/A | 42,089 | N/A | N/A |
| End Cash Position | N/A | N/A | 88,157 | N/A | N/A |
| Net Cash Flow | $N/A | $N/A | $46,068 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | N/A | -29,837 | N/A | N/A |
| Capital Expenditure | N/A | N/A | -63 | N/A | N/A |
| Free Cash Flow | 0 | 0 | -29,900 | 0 | 0 |